World Conference Calendar

32875 Conferences

PODD: Partnership Opportunities in Drug Delivery 2017, Boston, MA

Added by evvnt_Platform on 2017-08-18

Conference Dates:

Start Date Start Date: 2017-10-19
Last Date Last Day: 2017-10-20
Deadline for abstracts/proposals Deadline for abstracts/proposals: 2017-10-18

Conference Contact Info:

Contact Person Contact Person: PODD Team
Email Email: service@tcfllc.org
Address Address: Boston Marriott Copley Place, 110 Huntington Ave, Boston, 02116, United States
Phone Tel: 646 350 2580

Conference Description:

Chaired by Dr Barbara Lueckel, Head of Research and Technologies Partnering at Roche, the 7th Annual Partnership Opportunities in Drug Delivery (PODD) event will take place on October 19-20, 2017 at the Marriott Copley Place in Boston.

This annual conference is designed with three purposes:
1. To present a strategic level program for pharma and biotech business development professionals with a thorough overview of the latest drug delivery technologies available along with an update on deals and opportunities to improve therapies and extend the life cycle of a drug.
2. To provide drug delivery and specialty pharmas with a platform to present their technologies and get the latest insights on what the delivery and formulation needs are.
3. To offer ample networking time, facilities and services for one-on-one meetings to establish new business contacts and enhance existing ones.

Choose from 3 tracks (6 sessions) covering a broad range of enabling delivery technologies:
Track 1A: Injectable Technologies, chaired by Matthew Burke, PhD, Head of Drug Delivery, GSK
Track 2A: Oral Delivery Technologies, chaired by RenÚ Holm, PhD, Head and Scientific Director, Drug Product Development, Liquids and Parenterals, Janssen
Track 3A: Device Technologies, chaired by Mathias Romacker, Senior Director, Device Strategy, Pfizer
Track 1B: Injectable Technologies, chaired by Ulrich Bruggemann, Head Academics and Innovation, Global Medical Devices Development, Sanofi US
Track 2B: Non-Injectable Technologies: Transdermal and Transmucosal, chaired by Robert Saklatvala, PhD, Director, Discovery Pharmaceutical Sciences, Merck
Track 3B: Device Technologies, chaired by Justin Wright, PhD, VP, Drug Delivery Innovation, DDRandD Technology, Eli Lilly and Co

Learn about sponsorship and exhibition opportunities. Contact Customer Service at service@tcfllc.org or call 646-350-2580.

URL:
Website: https://go.evvnt.com/149433-1

Prices:
Standard starting rate: USD 1995,
Academic / Non-profit / Govt. starting rate: USD 997.50.

Speakers: Barbara Lueckel PhD, Omid Farokhzad MD, Jeffrey Karp PhD, Lars Rebien S°rensen, Ulrich Bruggemann, Matthew Burke PhD, RenÚ Holm PhD, Tugrul Kararli PhD MBA, Mathias Romacker, Robert Saklatvala PhD, Justin Wright PhD.

Time: 8:00 am to 5:00 pm
© 2017 World Conference Calendar. All rights reserved.
About WCC | News | FAQs | Links | Terms and Conditions | Privacy | Contact Us